Abbott acquires remaining 90% stake in Evalve - MarketLine Financial Deals

Abbott acquires remaining 90% stake in Evalve

Abbott acquires remaining 90% stake in Evalve - MarketLine Financial Deals
Abbott acquires remaining 90% stake in Evalve
Published Nov 02, 2009
3 pages — Published Nov 02, 2009
Price US$ 20.00  |  Buy this Report Now

About This Report

  
Abstract:

Abbott Laboratories has acquired Evalve, Inc., a designer, developer, and manufacturer of devices that enable the repair of cardiac valves.

  
Source:
Document ID
MA08805_090911
Country
Ticker
ABT=US
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "Abbott acquires remaining 90% stake in Evalve" Nov 02, 2009. Alacra Store. Dec 03, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Abbott-acquires-remaining-90-stake-in-Evalve-2052-8498>
  
APA:
MarketLine Financial Deals. (2009). Abbott acquires remaining 90% stake in Evalve Nov 02, 2009. New York, NY: Alacra Store. Retrieved Dec 03, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Abbott-acquires-remaining-90-stake-in-Evalve-2052-8498>
  
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.